Viewing StudyNCT04644315



Ignite Creation Date: 2024-05-06 @ 3:29 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04644315
Status: TERMINATED
Last Update Posted: 2023-08-07
First Post: 2020-11-20

Brief Title: A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Conditions & Keywords Data

Conditions:
Name
Central Nervous System
Neoplasms
Colorectal Neoplasms
Melanoma
Pancreatic Neoplasms
Sarcoma
Ovarian Neoplasms
Brain Neoplasms
Thyroid Neoplasms
Neuroendocrine Tumors
Cholangiocarcinoma
Salivary Gland Neoplasms
Head and Neck Neoplasms
Thyroid Cancer Papillary
Lymphoma Large-Cell Anaplastic
Neoplasms by Site
Respiratory Tract Neoplasms
Thoracic Neoplasms
Respiratory Tract Diseases
Carcinoma Bronchogenic
Bronchial Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Keywords:
Name View
ALK solid tumors View
agnostic View
ALK View
Alk-positive View
ALK positive View
ALK mutation View
GI View
breast View
sarcoma View
neuroendocrine View
female reproductive View
ALK View
ALK fusions View
ALK gene rearrangements View
colorectal cancer View
entrectinib View
basket study View
salivary gland cancers View
primary brain tumors View
melanoma View
sarcomas View
papillary thyroid cancer View
renal cell cancer View
pancreatic cancer View
breast cancer View
cholangiocarcinoma View
head neck cancers View
ovarian cancer View
anaplastic lymphoma kinase positive View
solid tumors View